Talam, Gwendolyn A.
HRN: 23-65-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2023
CEFUROXIME 500MG (TAB)
09/09/2023
09/15/2023
PO
500mg
BID
Retained Placenta, Non Institutional Delivery
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes